LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Cardiac Science Corp. Defibrillator Patent Infringement Settlement
Bothell, WA: (Apr-26-07) Cardiac Science Corp. and Philips had filed charges against each other over patent infringement of defibrillator technologies. In a settlement reached, both parties agreed to dismiss the long standing patent litigation by dropping all claims against each other. Each side granted rights to the respective defibrillation technology... - Zyprexa Hole Gets Deeper
May-1-07 Washington, DC: On March 7, 2007, Montana's attorney general, Mike McGrath, filed the latest Medicaid fraud lawsuit against Eli Lilly, under the False Claims Act, for illegally promoting the sale of the atypical antipsychotic drug Zyprexa for off-label uses and concealing its link to serious health problems. Considered to be one of the most effecti... - Independence Blue Cross Data Analysts Unpaid Overtime Settlement
Philadelphia, PA: (Apr-26-07) Ninety-one Independence Blue Cross quality data analysts filed a lawsuit against the company, accusing it of not providing stipulated overtime pay. On Feb. 6, analyst Elizabeth McGraw filed a lawsuit on behalf of herself and colleagues in Philadelphia Common Pleas Court, alleging that in March 2006, the health insurer decided... - Minebea Co., Ltd. PC Motor Patent Infringement Settlement
Chicago, IL: (Apr-25-07) Papst Licensing filed a patent infringement lawsuit against Minebea Co., Ltd., a multi-billion-dollar industrial company based in Tokyo, alleging that since 1997, Minebea tried to destroy Papst's licensing program. The lawsuit dealt with Papst Licensing's patents that cover motors and hard-disk drives found in virtually all persona... - Trasylol: The Side Effects could Kill You
Apr-29-07 San Bruno, CA: No one would argue the benefits of Trasylol for heart surgery. Effective for helping to minimize blood loss during surgical procedures, Trasylol nonetheless presents the potential for extreme side effects to internal organs: specifically the kidney, the brain and the heart. With the American Heart Association reporting more than six mil... - Lilly Receives Zyprexa Greetings From Capitol Hill
Apr-27-07 Washington, DC: The Chairman and CEO of Eli Lilly, Sidney Taurel, has become a regular pen pal with lawmakers on Capitol Hill since the company's ten-year campaign to increase profits by promoting the off-label use of Zyprexa for patients covered by public health care programs became the focus of investigations in both houses of Congress. According... - FDA Knew of Contamination Problems at Peanut Butter Plant for Years
Apr-26-07 Sylvester, GA: The Washington Post has reported that the Food and Drug Administration (FDA) knew for years about contamination at the Georgia ConAgra plant which produced peanut butter that has sickened more than 400 people across the US. In 2005, FDA inspectors were at the Sylvester-based plant to investigate complaints of an alleged episode of salmo... - Garry Donoghue Ex-CEO Contract Breach Settlement
New Zealand: (Apr-17-07) Text message marketer Plus SMS brought charges against its founder chief executive Garry Donoghue, forcing him to return $11 million worth of shares. The lawsuit stemmed from Donoghue refusing to hand back 85 million ordinary shares which apparently he was bound to return to the company when he resigned in 2006. As part of the nego... - Sandia National Laboratories Security Analyst Wrongful Termination Settlement
San Francisco, CA: (Apr-17-07) Shawn Carpenter, a former security analyst at Sandia National Laboratories, filed a wrongful termination lawsuit against the organization after being fired in January 2005 for sharing information related to an internal network compromise with the FBI and the US Army. Sandia stated that Carpenter had violated company rules by... - Zelnorm: The Benefits no longer Outweigh the Risks
Apr-20-07 East Hanover, NJ: The United States Food and Drug Administration (FDA) has announced that, at its request, Novartis Pharmaceuticals has stopped sales of Zelnorm . The action was taken after a study showed increased risk of serious side effects in people taking Zelnorm. The study, conducted by Novartis and submitted to the FDA, found that patients treat... - Goodyear Tires should not be on RVs
Apr-20-07 Akron, OH: Goodyear RV tires , Model number G159 275/70 22.5 were not designed for use on Class A RVs but they were used on such RVs from the mid-1990s to 2004. The tires have a history of de-treading and failures leading to accidents. Some of the accidents caused by tire failure have led to serious injury and death. The tires were initially designed f... - Arkansas, USA Department of Information Systems Billing Settlement
Little Rock, AR: (Apr-16-07) The US Department of Health and Human Services filed a lawsuit against state Department of Information Systems (DIS), alleging that the state owed $9.4 million for billing errors that occurred from fiscal year 1997 through fiscal year 2000. DIS provides information technology services like computers, Internet, data networking a... - Government Agencies Warn Against Zoloft During Pregnancy
Apr-13-07 Washington, DC: If you want a healthy baby, government agencies in both Canada and the United States warn that you might want to quit taking Zoloft during pregnancy. Last year, the U.S. Food and Drug Administration and its Canadian counterpart, Health Canada, both issued warnings about combining Zoloft and pregnancy. "A recently published case-contro... - Seroquel Lawsuits Filed Over Diabetes Risk
Apr-13-07 Wilmington,DE A class action lawsuit has been filed in Florida on behalf of patients who took Seroquel , claiming that the manufacturer AstraZeneca knew about the risk of diabetes but failed to properly warn doctors or patients. The lawsuit further claims that AstraZeneca promoted Seroquel for off-label uses. According to data released at a medical con... - Patients Diagnosed Schizophrenic and Bipolar to boost Seroquel Sales
Apr-11-07 Washington, DC: For over a decade, drug makers have been influencing doctors to diagnose patients, especially those covered by public health care programs like Medicare and Medicaid, with mental illnesses to justify the over-prescribing of the new class of drugs known as "atypical" antipsychotics. For instance, Seroquel , marketed by AstraZeneca, is on... - L. Eric Whetstone Safari Breach of Contract Settlement
League City, TX: (Apr-04-07) Swanepoel & Scandrol Safaris of League City filed a lawsuit in federal district court in Texas in September 2005 against L. Eric Whetstone, owner of the former Miller Brewery in Tumwater, alleging that Whetstone never paid for two African safaris and two target animals, a lion and a rhinoceros. Denying allegations, Whetstone, a... - Medical Devices - April 2007 Litigation Update (Part II)
Apr-9-07 ( Part I ) Washington, DC: By the fall of 2006, sitings of a whole new batch of litigants were looming on the horizon for both Boston and Johnson & Johnson. October 23, 2006, the Boston Globe, reported, "as more evidence emerges that suggests drug-coated stents have caused higher rates of blood clots than the older generation of bare-metal stents, doc... - Consumer Credit Information Protection: Not All Companies Follow the Rules
Apr-7-07 Fort Worth, TX: Two high profile incidents in which consumer personal information was made vulnerable have highlighted the importance of companies following rules designed to protect consumer credit information. When companies do not follow those rules consumers are at risk of becoming victims of identity theft. Texas Attorney General Greg Abbott has... - PPH linked to Fen Phen before Drug was Approved
Apr-7-07 Madison, NJ: Since American Home Products announced that its diet drug combination fen phen was being pulled from the market, thousands of lawsuits have been filed against the drug maker. Eleven thousand lawsuits that were settled by American Home Products cost the company $4.83 billion. Lawsuits that were filed claimed that fen phen caused the diet drug u... - FDA Finally Yanks Permax Off the US Market
Apr-6-07 Washington, DC: On March 29, 2007, the FDA withdrew Permax (pergolide) from the market because it increases the risk of valvular heart disease. Permax belongs to a class of drugs known as dopamine agonists that help regulate balance and movement in Parkinson's patients who suffer from a lack of dopamine. When Permax was FDA approved in 1988, Eli Lilly...